BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18314420)

  • 1. Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle.
    Bouzakri K; Austin R; Rune A; Lassman ME; Garcia-Roves PM; Berger JP; Krook A; Chibalin AV; Zhang BB; Zierath JR
    Diabetes; 2008 Jun; 57(6):1508-16. PubMed ID: 18314420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism.
    Dyck JR; Berthiaume LG; Thomas PD; Kantor PF; Barr AJ; Barr R; Singh D; Hopkins TA; Voilley N; Prentki M; Lopaschuk GD
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):599-608. PubMed ID: 10947976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
    Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
    J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
    Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
    Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence against a sexual dimorphism in glucose and fatty acid metabolism in skeletal muscle cultures from age-matched men and post-menopausal women.
    Rune A; Salehzadeh F; Szekeres F; Kühn I; Osler ME; Al-Khalili L
    Acta Physiol (Oxf); 2009 Nov; 197(3):207-15. PubMed ID: 19508405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of genes regulating malonyl-CoA in human skeletal muscle.
    Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
    J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
    Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
    Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-specific regulation of malonyl-CoA decarboxylase activity in OLETF rats.
    Kim HJ; Zhao ZS; Lee YJ; Shim WS; Kim SK; Ahn CW; Park CW; Lee HC; Cha BS
    Diabetes Obes Metab; 2006 Mar; 8(2):175-83. PubMed ID: 16448521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells.
    Zhou W; Tu Y; Simpson PJ; Kuhajda FP
    Oncogene; 2009 Aug; 28(33):2979-87. PubMed ID: 19543323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.
    Koves TR; Ussher JR; Noland RC; Slentz D; Mosedale M; Ilkayeva O; Bain J; Stevens R; Dyck JR; Newgard CB; Lopaschuk GD; Muoio DM
    Cell Metab; 2008 Jan; 7(1):45-56. PubMed ID: 18177724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle.
    Bouzakri K; Zachrisson A; Al-Khalili L; Zhang BB; Koistinen HA; Krook A; Zierath JR
    Cell Metab; 2006 Jul; 4(1):89-96. PubMed ID: 16814735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance.
    Turpin SM; Lancaster GI; Darby I; Febbraio MA; Watt MJ
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1341-50. PubMed ID: 16849630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-mediated effects on metabolism are reversed by targeting 11 beta hydroxysteroid dehydrogenase type 1 in human skeletal muscle.
    Salehzadeh F; Al-Khalili L; Kulkarni SS; Wang M; Lönnqvist F; Krook A
    Diabetes Metab Res Rev; 2009 Mar; 25(3):250-8. PubMed ID: 19222059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different impacts of saturated and unsaturated free fatty acids on COX-2 expression in C(2)C(12) myotubes.
    Kadotani A; Tsuchiya Y; Hatakeyama H; Katagiri H; Kanzaki M
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1291-303. PubMed ID: 19755671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of malonyl-CoA decarboxylase reduces the inflammatory response associated with insulin resistance.
    Samokhvalov V; Ussher JR; Fillmore N; Armstrong IK; Keung W; Moroz D; Lopaschuk DG; Seubert J; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2012 Dec; 303(12):E1459-68. PubMed ID: 23074239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential carnitine/acylcarnitine translocase expression defines distinct metabolic signatures in skeletal muscle cells.
    Peluso G; Petillo O; Margarucci S; Grippo P; Melone MA; Tuccillo F; Calvani M
    J Cell Physiol; 2005 May; 203(2):439-46. PubMed ID: 15515015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin-mediated inhibition of mammalian target of rapamycin in skeletal muscle cells reduces glucose utilization and increases fatty acid oxidation.
    Sipula IJ; Brown NF; Perdomo G
    Metabolism; 2006 Dec; 55(12):1637-44. PubMed ID: 17142137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted suppression of calpain-10 expression impairs insulin-stimulated glucose uptake in cultured primary human skeletal muscle cells.
    Brown AE; Yeaman SJ; Walker M
    Mol Genet Metab; 2007 Aug; 91(4):318-24. PubMed ID: 17572128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle.
    Glund S; Deshmukh A; Long YC; Moller T; Koistinen HA; Caidahl K; Zierath JR; Krook A
    Diabetes; 2007 Jun; 56(6):1630-7. PubMed ID: 17363741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes.
    Palanivel R; Fang X; Park M; Eguchi M; Pallan S; De Girolamo S; Liu Y; Wang Y; Xu A; Sweeney G
    Cardiovasc Res; 2007 Jul; 75(1):148-57. PubMed ID: 17499232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.